分子療法-核酸是一種國(guó)際性的、開放獲取的期刊，在核酸療法治療和/或糾正遺傳和獲得性疾病的廣泛領(lǐng)域中，出版高質(zhì)量的基礎(chǔ)、翻譯和臨床研究。研究領(lǐng)域包括但不限于:基于核酸及其衍生物的治療方法的開發(fā)、基于rna的治療方法的載體開發(fā)和設(shè)計(jì)、基因修飾劑的應(yīng)用，包括形成三聚體的寡核苷酸和酶(如鋅指核酸酶)、臨床前目標(biāo)驗(yàn)證、安全性/有效性研究和臨床試驗(yàn)。分子治療-核酸2015影響因子為5.048。

Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy — Nucleic Acids 2015 impact factor is 5.048.